Emily Elizabeth Devine
My passion for the multidisciplinary field of health economics and outcomes research is motivated by my desire to ensure that we, as scientists, provide the best value for investments made – for our individual patients, for populations under our care, and for the health(care) sector of society.
I am particularly passionate about applying the most rigorous and appropriate study designs and analytic methods to accurately answer relevant questions in the areas of comparative effectiveness of health technologies, precision medicine, and patient centered outcomes.
I am also passionate about training the next generation of scientists in Health Economics and Outcomes Research
I am a tenured Professor in the School of Pharmacy, University of Washington (UW). I am honored to hold the Shirley and Herb Bridge Endowed Professor for Women in Pharmacy. I hold adjunct appointments in the Departments of Health Services and Biomedical Informatics; and am a member of the Institute for Public Health Genetics and the Plein Center for Geriatric Pharmacy Research.
I am privileged to be a Fulbright US Scholar (Fall 2021) and a Visiting Professor (January-June 2022) at the University of Murcia, School of Medicine, Department of Health Services Research, in Murcia, España.
I am a member of the Board of Directors of ISPOR-the leading professional society for Health Economics and Outcomes Research, an Associate Editor for the ISPOR journal Value in Health, and a member of the Academy Health Methods and Data Council.
I am an Assistant Director of the AHRQ-funded Pacific Northwest Evidence-based Practice Center, an elected member of the Society for Research Synthesis Methodology and served on the ISPOR Task Force that developed guidelines to conduct network meta-analyses.
Prior to joining the faculty at the UW, I was an advanced practice (prescribing) clinical pharmacist and formulary lead at the University of California San Francisco, where I served a term as president of the California Society of Health-System Pharmacists, earning their Lifetime Achievement Award for my leadership role in advancing the scope of practice for California pharmacists through legislation (1994).
Research Program Summary
Health economics and outcomes research is a multidisciplinary field that employs methods from the overlapping disciplines of epidemiology, biostatistics, decision sciences, health economics and health policy.
Trained in both health services research and health economics, I focus on the following areas of research, I:
1. Apply my expertise to evidence synthesis projects, where I conduct systematic reviews and employ Bayesian and frequentist methods to conduct network meta-analyses and meta-analyses.
Cha AS, Chen Y, Fazioli K, Rivara M, Devine, B. Microvascular benefits of new antidiabetic agents: A systematic review and network meta-analysis of renal outcomes. J Clin Endocrinol Metab. 2021 Mar 25;106(4):1225-1234. doi: 10.1210/clinem/dgaa894
Wang WJ, Devine B, Basu A. Use of the convoluted Poisson process in systematic reviews. Res Synth Methods 2020 Nov 1. doi: 10.1002/jrsm.1465. Online ahead of print.
Dhippayom T, Rattanachaisit N, Jhunsom S, Dilokthornsakul P, Chaiyakunapruk N, Devine B. Comparative effects of telemedicine and face-to-face anticoagulation management: A systematic review and network meta-analysis. J Am Pharm Assoc (2003). Nov-Dec 2020;60(6):880-891.e9. doi: 10.1016/j.japh.2020.06.010. Epub 2020 Jul 21.
Dhippayom T, Devine B. Letter to the editor for a published article titled, “The effect of online versus hospital warfarin management on patient outcomes: A systematic review and meta-analysis. Int J Clin Pharm. April 2, 2020. https://doi.org/10.1007/s11096-019-00947-8.
Jiao B, Baldwin Z, Basu A, Roth J, Bender MA, Devine B. Estimates of the Cost-effectiveness of Screening and Treatments for Sickle Cell Disease: A Systematic Review and Landscape Analysis. (in press at PharmacoEconomics, Aguust 2021)
Jiao B, Baldwin Z, Basu A, Roth J, Bender MA, Devine B. Health State Utilities for Sickle Cell Disease: A Systematic Review and Landscape Analysis. (in press at Value Health, August 2021)
Baldwin Z, Jiao B, Basu A, Roth J, Bender MA, Devine B. Medical and non-medical costs of sickle cell disease, treatments, and related complications: A Systematic Review and Landscape Analysis. (under review at PharmacoEconomics Open, December 2021)
Quach D, Devine B, et al. Gene therapies for Sickle Cell Disease. A Systematic Review and Landscape Analysis. (under revision at Expert Rev Pharmacoecon Outcomes Res)
Chua S, Devine B, Todd A, Huang Y, Hughes S, Elsisi Z, Husband A, Gray SL, and members of the US Deprescribing Network Systematic Review Panel. Effectiveness of deprescribing interventions in older adults: An overview of systematic reviews. (intended for BMJ, December 2021)
Chen S, Devine B, Basu A. Understanding drug price changes with respect to more generic competition: A systematic literature review and Bayesian meta-analysis. (intended for Value Health, Spring 2021)
2. Explore the effectiveness of pharmacogenomic and genomic biomarker-guided medication use on clinical
outcomes, using real world evidence in the context of clinical informatics and electronic health record data.
Jiang S, Mathias, Hendrix N, Shirts B, Veenstra DL, Devine B. Customizing value-based methods to prioritize implementation of pharmacogenomic clinical decision support for Learning Health Systems: A cost-utility analysis. (under revision at The Pharmacogenomics Journal, December 2021)
Chaitesipaseut L, Wilson-Norton J, Trivelli K, Mikes T, Devine B. Feasibility of conducting pharmacogenomic-guided medication therapy management in retirement communities. (in press at J Am Coll Clin Pharm, October 2021)
Knerr S, Guo B, Mittendorf KF, Goddard KAB, Devine EB and the CHARM Study Team. Risk-reducing surgery in unaffected women receiving cancer genetic testing in an integrated healthcare system. (under review at J Clin Onc, July 2021)
3. Address decision problems in health technology assessment and outcomes research including preference-
based methods, discrete choice experiments and multi-criteria decision analysis.
Saldarriaga EM, Hauber B, Carlson JJ, Barthold D, Veenstra DL, Devine B. Assessing payers’ preferences for real world evidence: A discrete choice experiment. (in press at Value Health, October 2021)
Lee D, Kim Y, Devine B. Spillover effects of mental disorders on family members’ utility: SF-6D scores from a US sample. 2021 Aug 11:272989X211027146. doi: 10.1177/0272989X211027146. Online ahead of print. PMID: 34378438
Hendrix N, Kim DD, Patel KS, Devine B. Differences in the selection of health state utility values by sponsorship in published cost-effectiveness analyses. Med Decis Making. 2021 Apr;41(3):366-372. doi: 10.1177/0272989X20985821. Epub 2021 Jan 15.
Chen S, Yun S, Graf J, Beal B, Bansal A, Carlson J, Basu A, Devine B. The REAdi (Real-World Evidence Assessments and Needs Guidance) Tool: A Framework for Evaluating Real-World Evidence. J Manag Care Spec Pharm. 2021 Jan;27(1):95-104. doi: 10.18553/jmcp.2021.27.1.095.
Jiao B, Veenstra D, Lee W, Carlson J, Devine B. The use of real-world evidence in ICER’s scoping process and clinical evidence assessment. J Manag Care Spec Pharm. 2020 Dec;26(12):1590-1595. doi: 10.18553/jmcp.2020.26.12.1590.
My work is funded by the US Agency for Healthcare Research and Quality. I also lead projects funded by the NIH (National Cancer Institute; National Heart, Lung and Blood Institute; National Institute on Aging) and the US Department of Veterans Affairs. I am currently a co-investigator on the Electronic Medical Records and Genomics (eMERGE 4) Network and the Clinical Sequencing Evidence-Generating Research (CSER 2), both national consortia funded by the NIH-National Human Genome Research Institute.
I teach methods courses on the UW Health Sciences campus. In the CHOICE Graduate Program I teach Assessing Outcomes in Health and Medicine. In the Doctor of Pharmacy program, I teach the fundamentals of biostatistics and epidemiology to facilitate critical literature evaluation. I also teach health technology assessment in our distance learning program in Health Economics and Outcomes Research.
Primary Academic Appointment
The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute
Formerly Pharmaceutical Outcomes Research and Policy Program (PORPP)
Department of Pharmacy, University of Washington
2021 - Shirley and Herb Bridge Endowed Professor for Women in Pharmacy
2021-2022 - Fulbright US Scholar (Fall 2021) and a Visiting Professor (January-June 2022), University of Murcia, Murcia, España
Adjunct Academic Appointments
Adjunct, Department of Health Services, School of Public Health
Adjunct, Department of Biomedical Informatics, School of Medicine
Member, Institute for Public Health Genetics
Member, Plein Institute for Geriatric Pharmacy Practice
Administrative Academic Appointments
University of Washington
2016 - Director, Graduate Program, The CHOICE Institute
Selected Honors & Awards
Visiting Professor, University of Murcia, Murcia, España
Fulbright Senior Scholar, University of Murcia, Murcia, España (Fall)
Nominated for the UW-wide Marsha L. Landolt Distinguished Graduate Mentor of the Year Award
2021 - 2024
Elected member, ISPOR Board of Directors
2021 - 2025
Associate Editor, Value in Health
Guest Editor, Theme section on Remote Patient Monitoring, Value in Health
Nominated for Faculty Mentor of the Year Award, UW School of Pharmacy (June)
Nominated for Institute of Medicine Anniversary Pharmacy Fellowship
Elected member, Society for Research Synthesis Methodology
Member, Beta Gamma Sigma National Business Honor Society
Fellow, American Society of Health-System Pharmacists
Pharmacist of the Year Lifetime Achievement Award, California Society of Health-System Pharmacists
Member, Phi Lambda Sigma, Pharmacy Leadership Society
Education & Training
2005 - 2008
PhD in Health Services Research, Dept of Health Services, School of Public Health, UW, Seattle WA Dissertation: “Evaluating the impact of an ambulatory computerized provider order entry system on outcomes in a community-based multispecialty health system”
1999 - 2001
Post-doctoral Fellowship in Pharmacoeconomics and Outcomes Research, UW, Seattle, WA and Roche Global Pharmacoeconomics, Palo Alto, CA
1997 - 1999
Master in Business Administration, Masagung Graduate School of Business and Management, University of San Francisco, San Francisco, CA Thesis: “UCSF Pharmacy Faculty Practice Consortium: A plan for optimizing medication use in physician group practices”
1978 - 1979
Clinical Pharmacy Residency, Veterans Administration Health Care System, Palo Alto, CA
1975 - 1978
Doctor of Pharmacy degree, University of the Pacific, Stockton, CA
1973 - 1975
Pre-pharmacy, University of the Pacific, Stockton, CA Music minor, Conservatory of Music, University of the Pacific, Stockton, CA